Benlysta 200 mg/mL single-dose prefilled autoinjector Images
Generic Name: belimumab
This medication has been identified as Benlysta 200 mg/mL single-dose prefilled autoinjector. It is supplied by GlaxoSmithKline.
Benlysta is used in the treatment of Lupus; Lupus Erythematosus; Lupus Nephritis and belongs to the drug class selective immunosuppressants. Risk cannot be ruled out during pregnancy. Benlysta 200 mg/mL single-dose prefilled autoinjector is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication

Benlysta
- Generic Name
- belimumab
- Strength
- 200 mg/mL single-dose prefilled autoinjector
- Availability
- Prescription only
- Drug Class
- Selective immunosuppressants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- GlaxoSmithKline
- National Drug Code (NDC)
- 49401-0088
More about Benlysta (belimumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (61)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: selective immunosuppressants
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.